Vir Biotechnology, Inc. VIR Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s other income, net (note 6)?
- Vir Biotechnology, Inc. (VIR) reported other income, net (note 6) of -$254K in Q1 2026.
- How has Vir Biotechnology, Inc.'s other income, net (note 6) changed year-over-year?
- Vir Biotechnology, Inc.'s other income, net (note 6) decreased by 252.8% year-over-year, from -$72K to -$254K.
- What is the long-term trend for Vir Biotechnology, Inc.'s other income, net (note 6)?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s other income, net (note 6) has grown at a -64.9% compound annual growth rate (CAGR), from -$9.44M to -$409K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.